Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

2012 Deep Research Report on Global and China Coronary Stent Industry

503 views

Published on

  • Be the first to comment

  • Be the first to like this

2012 Deep Research Report on Global and China Coronary Stent Industry

  1. 1. 2012 Deep Research Report on Global and China Coronary StentIndustryReport Details:Published:October 2012No. of Pages: 235Price: Single User License – US$20002012 Deep Research Report on Global and China Coronary Stent Industry was professional anddepth research report on China Coronary Stent industry. The report firstly introduced CoronaryStent basic information included Coronary Stent definition classification application industry chainstructure industry overview; international market analysis, China domestic market analysis,Macroeconomic environment and economic situation analysis and influence, Coronary Stentindustry policy and plan, Coronary Stent product specification, manufacturing process, productcost structure etc. then statistics Global and China key manufacturers Coronary Stent capacityproduction cost price profit production value gross margin etc details information, at the sametime, statistics these manufacturers Coronary Stent products customers application capacitymarket position company contact information etc company related information, then collect allthese manufacturers data and listed Global and China Coronary Stent capacity productioncapacity market share production market share supply demand shortage import exportconsumption etc data statistics, and then introduced Global and China Coronary Stent 2009-2013capacity production price cost profit production value gross margin etc information. And also listedCoronary Stent upstream raw materials equipments and Down stream clients alternative productssurvey analysis and Coronary Stent marketing channels industry development trend andproposals. In the end, this report introduced Coronary Stent new project SWOT analysisInvestment feasibility analysis investment return analysis and also give related researchconclusions and development trend analysis of Global and China Coronary Stent industry. In aword, it was a depth research report on Global and China Coronary Stent industry. And thanks tothe support and assistance from Coronary Stent industry chain related technical experts andmarketing engineers during Research Team survey and interviews.Get your copy of this report @http://www.reportsnreports.com/reports/202272-2012-deep-research-report-on-global-and-china-coronary-stent-industry.htmlMajor points covered in Table of Contents of this report include
  2. 2. Table of ContentsChapter One Coronary Stent Industry Overview 11.1 Coronary Stent Definition 11.2 Coronary Stent Classification and Application 21.3 Coronary Stent Operation 41.4 Coronary Stent Industry Chain Structure 101.5 Coronary Stent Industry Overview 14Chapter Two Coronary Stent International and China Market Analysis 212.1 Coronary Stent Industry International Market Analysis 222.1.1 Coronary Stent International Market Development History 222.1.2 Coronary Stent Product and Technology Developments 232.1.3 Coronary Stent Competitive Landscape Analysis 302.1.4 Coronary Stent International Key Countries Development Status 352.1.5 Coronary Stent International Market Development Trend 392.2 Coronary Stent Industry China Market Analysis 452.2.1 Coronary Stent China Market Development History 452.2.2 Coronary Stent Product and Technology Developments 462.2.3 Coronary Stent Competitive Landscape Analysis 502.2.4 Coronary Stent China Key Regions Development Status 522.2.5 Coronary Stent China Market Development Trend 562.3 Coronary Stent International and China Market Comparison Analysis 60Chapter Three Coronary Stent Development Environmental Analysis 633.1 China Macroeconomic Environment Analysis 633.1.1 China GDP Analysis 633.1.2 China CPI Analysis 653.2 European Economic Environmental Analysis and Impact 693.3 United States Economic Environmental Analysis and Impact 723.4 Global Economic Environmental Analysis and Impact 75Chapter Four Coronary Stent Development Policy and Plan 764.1 China Government Policy and Development Plan 764.1.1 China Medical and Health System Reform in 2011-2015(12th Five Year) 764.1.2 2012 Medical Device Support Policy 784.1.3 "12th Five-Year Plan" other Reform Focus 794.1.4 <Healthy China 2020> Strategy Plan 794.2 Sub-Industry Policy Analysis 804.3 Local Policy and Development Analysis 834.4 Downstream Industry Policy and Demand Analysis 844.5 Hotspots and Influence Analysis 85
  3. 3. Chapter Five Coronary Stent Manufacturing Process and Cost Structure 865.1 Coronary Stent Product Specifications 865.2 Coronary Stent Manufacturing Process Analysis 925.3 Coronary Stent Cost Structure Analysis 94Chapter Six 2009-2013 Coronary Stent Productions Supply Sales Demand Market Statusand Forecast 956.1 2009-2013 Coronary Stent Capacity Production Overview 956.2 2009-2013 Coronary Stent Production Market Share Analysis 1026.3 2009-2013 Coronary Stent Demand Overview 1096.4 2009-2013 Coronary Stent Supply Demand and Shortage 1136.5 2009-2013 Coronary Stent Import Export Consumption 1156.6 2009-2013 Coronary Stent Cost Price Production Value Gross Margin 115Chapter Seven Coronary Stent Key Manufacturers Analysis 1167.1 Boston Scientific 1167.2 Abbott Laboratories 1277.3 Medtronic 1327.4 J&J Cordis 1387.5 Biosensors International 1407.6 Biotronik 1457.7 OrbusNeich 1517.8 Sorin Group 1587.9 B.Braun 1627.10 C. R. Bard 1657.11 MicroPort 00853.HK 1687.12 Lepu Medical 30003.CH 1767.13 Jiwei Medical Systems 1837.14 Liaoning Biomedical 1887.15 Vascore 1927.16 Sinomed--Fujiyangguang 1957.17 ESSEN 1997.18 Kinhely 2027.19 Medfavour Medical 2037.20 Suzhou Huanchen Medical 204Chapter Eight Up and Down Stream Industry Analysis and Influence 2058.1 Upstream Raw Materials Price Analysis and Influence 2058.2 Upstream Equipments Market Analysis and Influence 2078.3 Down Stream Demand Analysis and Influence 2078.4 Alternative Products Analysis and Influence 209
  4. 4. Chapter Nine Coronary Stent Marketing Channels Analysis 2129.1 Coronary Stent Marketing Channels Status 2129.2 Coronary Stent Marketing Channels Management 2139.3 Coronary Stent Marketing Channels Establishment 2149.4 Coronary Stent Marketing Channels Development Trend 215Chapter Ten Coronary Stent Industry Development Trend 21710.1 2012-2016 Coronary Stent Development Trend 21710.2 2012-2016 Market Potential Forecast 21810.3 2012-2016 R&D Trend 21910.4 2012-2016 Marketing Channels Change Trend 22010.5 2012-2016 Competition Pattern Development Trends 22110.6 2012-2016 Import Export Development Trend 222Chapter Eleven Coronary Stent Industry Development Proposals 22311.1 Macroeconomic Development Countermeasures 22311.2 New Firms Enter Market Strategy 22611.3 New Project Investment Proposals 22911.4 Marketing Channel Strategy Proposals 23111.5 Competitive Environment Strategy Proposals 231Chapter Twelve Coronary Stent New Project Investment Feasibility Analysis 23312.1 Coronary Stent Project SWOT Analysis 23312.2 Coronary Stent New Project Investment Feasibility Analysis 233Chapter Thirteen China Coronary Stent Industry Research Conclusions 234List Of Tables and FiguresFigure Coronary Stent Picture 1Table Coronary Stent Classification List 2Figure Coronary Stent Application 3Figure Coronary Stent Indications List 3Figure Coronary Stent Operation Process Figure 4Figure Coronary Stent Operation Diagram 5Figure Angiography Diagram 5Figure Balloon into the Stenosis Site and Balloon Dilatation 7Figure Coronary Stent Before and After Operation Comparison 9Figure PCI Operation key Devices 10Figure Medical Devices Industry Classification 11Table Medical Devices Industry Segments and Description of the Apparatus 11
  5. 5. Figure Interventional Medical Devices Classification 12Figure Coronary Stent Supply Chain Model 13Figure Coronary Stent Industry Chain Structure 14Figure Coronary Stent R&D Trend 25Figure Drug Eluting Stent R&D History 26Figure 2011 US EU Japan China etc Regional Coronary Stent Production Market Share 30Figure 2009-2015 Global Drug Eluting Stent Proportion of Total Stents 31Figure 2011 Global and US Drug Eluting Stent Market Share 31Table International Coronary Stent Key Suppliers and Their Key Products List 32Table United States Coronary Stent Market Competitive Landscae Development History 32Figure 2009 Global Coronary Stent Suppliers Market Share 33Table Global 79 Coronary Stent Manufacturers List 33Figure United States Europe Japan China Medical Device Production Values Market Share 40Figure 2010-2016 Global Regional Coronary Stent System Sales Revenue (Million USD) 41Table 2009-2016 Global Medical Device Market Scale (100 Million USD) and InterventionalMedical Device Market Scale (100 Million USD) 41Figure 2009-2016 Global Medical Device and Interventional Medical Device Market Scale (100Million USD) and Their Growth Rate 42Table 2009-2016 Global Drug Eluting Stent Coronary Stent and Cardiovascular InterventionalDevices Market Scale (100 Million USD) 42Figure 2009-2016 Global Coronary Stent and Cardiovascular Interventional Devices Market Scale(100 Million USD) and Their Growth Rate 43Figure 2009-2016 Global Drug Eluting Stent and Coronary Stent Market Scale (100 Million USD)and Their Growth Rate 43Table 2009 Global Cardiovascular Interventional Devices Classification and Sales Revenue (100Million USD) 44Figure Global Cardiovascular Interventional Devices Products Production Value Market Share45Figure 1st Generation Coronary Stent-Bare Metal Stent (BMS) 46Figure 2nd Generation Coronary Stent-Drug Eluting Stent (DES) 47Figure 3rd Generation Coronary Stent- Soluble Stent 48Figure Medical Device Sales Revenue by Regions such as Guangdong Shanghai BeijingShandong Jiangsu etc 54Table Shanghai Beijing Guangzhou Shenzhen Qinghai Hunan Inner Mongolia etc Stent SubsidiesList 55Figure China Medical Insurance Mode Distribution 56Figure 2000-2012 China PCI Operation (10K Pieces) 57Figure 2007-2014 China Coronary Stent Market Scale (100 Million RMB) 57Figure 2008-2015 China PCI Operation (10K Pieces) and Coronary Stent Market Scale (100Million RMB) 58Figure 2008-2010 China Coronary Stent Drug Eluting Stent and Bare Metal Stent Market Share58
  6. 6. Figure 2009 China Coronary Stent Suppliers Sales Revenue Market Share 59Figure 2009 China Coronary Stent Suppliers Sales Quantity Market Share 59Table China and Unites States Suppliers Drug Eluting Stent Product Price Table Comparison 60Table China and United States Players Coronary Stent Product Specifications Comparison 61Table International and China Key Drug Eluting Stent Type and Specifications List 61Figure 2006-2015 China Medical Device Production Value (100 Million RMB) and Growth Rate63Figure 20001-2011 China GDP (100 Million RMB) and Growth Rate 64Figure 2007-2011 China Medical Device Market Scale (100 Million RMB) and Proportion of GDP64Figure 1980-2030 China Urban Population (10K Persons) Forecast 65Table 2006-2011 China GDP (100 Million RMB) and Growth Rate 65Figure 2007-2011 China Cardiovascular Stent Market Scale (Billion RMB) and Growth Rate 66Figure 2007-2015 China Individual Medical Expenditure (RMB) 66Figure 2007-2015 China Total Individual Medical Expenditure and Government MedicalExpenditure (100 Million USD) 67Figure 2011-2016 China Population Growth and Aging Condition 68Figure 2000-2011 China PCI Operation (Piece) and Growth Rate 68Figure Europe GDP Development Trend 70Figure Europe Several Countries PMI Change Trend 70Figure United States CPI and PCE Growth Rate Comparison 73Figure Unites States Private Saving Change and Net Export/GDP Change Trend 74Figure United States Public Debt and Financial Deficits Proporation in GDP 74Table “Twelfth Five-Year Plan” Period of Deepening Reform of Medical and Health SystemPlanning and Implementation 76Table Global Drug Eluting Stent Suppliers and Its Products 86Figure Drug Eluting Stent Manufacturing Process Flow 91Figure Drug Eluting Stent Structure 91Figure Drug Eluting Stent System Structure 92Figure Bare Metal Stent Manufacturing Process Flow 93Figure Drug Eluting Stent Manufacturing Process Flow 94Table 2012 China Coronary Stent Cost Structure List 95Table 2009-2013 Global 16 Manufacturers Coronary Stent Capacity and Total Capacity (10KPieces) List 95Table 2009-2013 Global 16 Manufacturers Coronary Stent Capacity Market Share List 96Table 2009-2013 Global 16 Manufacturers Coronary Stent Production and Total Production (10KPieces) List 97Table 2009-2013 Global 16 Manufacturers Coronary Stent Production Market Share List 97Figure 2009-2013 Global Coronary Stent Capacity Production (10K Pieces)and Growth Rate 98Table 2009-2013 Global Coronary Stent Capacity Utilization Rate List 99Table 2009-2013 China 6 Manufacturers Coronary Stent Capacity and Total Capacity (10KPieces) List 99
  7. 7. Table 2009-2013 China 6 Manufacturers Coronary Stent Capacity Market Share List 99Table 2009-2013 China 6 Manufacturers Coronary Stent Production and Total Production List100Table 2009-2013 China Major Manufacturers Coronary Stent Production Market Share List 100Figure 2009-2013 China Coronary Stent Capacity Production and Growth Rate 101Table 2009-2013 China Coronary Stent Capacity Utilization Rate List 101Figure 2011 Global 16 Manufacturers Coronary Stent Production Market Share 102Figure 2012 Global 16 Manufacturers Coronary Stent Production Market Share 103Figure 2011 China 6 Manufacturers Coronary Stent Production Market Share 103Figure 2012 China Major Manufacturers Coronary Stent Production Market Share 104Table 2009-2013 Major Manufacturers Coronary Stent China Sales (10K Pieces) List 104Table 2009-2013 Major Manufacturers Coronary Stent China Sales Market Share List 105Figure 2011 Major Suppliers Coronary Stent China Sales Market Share 106Figure 2012 Major Suppliers Coronary Stent China Sales Market Share 106Figure 2011 Global Drug Eluting Stent Bare Metal Stent Market Share 107Figure 2011 China Drug Eluting Stent Bare Metal Stent Market Share 107Table 2009-2013 Global Drug Eluting Stent and Coronary Stent Market Scale (100 Million USD)107Table 2009-2013 Global Coronary Stent and Cardiovascular Interventional Devices Market Scale(100 Million USD) 108Figure 2009-2013 Global Drug Eluting Stent and Coronary Stent Market Scale (100 Million USD)and Growth Rate 108Figure 2009-2013 Global Coronary Stent and Cardiovascular Interventional Devices Market Scale(100 Million USD) and Growth Rate 109Table China Morbidity of Chronic Diseases (‰) 109Table 2008 China Urban and Rural Coronary Mortality Statistics (1/100000) 110Table Global and China Coronary Mortality Comparison 110Table 2009-2013 Global Coronary Stent Price(USD/Piece) Production (10K Pieces) ProductionValue (100 Million USD) 111Table 2009-2013 China Coronary Stent Price(USD/Piece) Production (10K Pieces) ProductionValue (100 Million USD) 111Table 2009-2013 Global and China Coronary Stent Sales (10K Pieces) List 111Figure 2009-2013 Global PCI Operation (10k Pieces) Coronary Stent Consumption (10K Pieces)and Growth Rate 112Figure 2009-2013 PCI Operation (10k Pieces) Coronary Stent Consumption (10K Pieces) andGrowth Rate 112Table 2009-2013 Global Coronary Stent Supply Demand Shortage (10K Pieces) List 113Table 2009 China Coronary Stent Demand 113Table 2009-2013 China Coronary Stent Supply Production Shortage (10K Pieces) List 114Table 2009-2013 China Coronary Stent Supply Demand Shortage (10K Pieces) List 114Table 2009-2013 China Coronary StentProduction Import Export Consumption (10K Pieces) List115
  8. 8. Table 2009-2013 Global Coronary Stent Production (10K Pieces) Price Cost Gross (USD/Piece)Production Value (10K USD) Gross Margin List 115Table 2009-2013 China Coronary Stent Production (10K Pieces) Price Cost Gross (USD/Piece)Production Value (10K USD) Gross Margin List 116Table Boston Scientific Company Information Table (Products Applications Manufacturing BaseCapacity Expansion Market Position Contact Information Etc 13 Items) 116Figure Boston Scientific Medical Business Structure 121Figure Boston ScientificVeriFLEX® Bare-Metal Coronary Stent System 122Figure Boston Scientific Drug-Eluting Stents 123Figure ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System 123Figure Boston Scientific TAXUS® Express²® Coronary Stent 125Table 2009-2013 Boston Scientific Coronary Stent Production (10K Pieces) Price Cost Gross(USD/Piece) Production Value (10K USD) Gross Margin List 126Figure 2009-2013 Boston Scientific Coronary Stent Capacity Production (10K Pieces) and GrowthRate 126Table Abbott Laboratories Company Information Table (Products Applications Manufacturing BaseCapacity Expansion Market Position Contact Information Etc 13 Items) 127Figure Abbott Laboratories MULTI-LINK 8 LL Coronary Stent System 128Figure Abbott Laboratories XIENCE Everolimus Eluting Coronary Stent System 129Figure Abbott Laboratories MULTI-LINK VISION Coronary Stent System 130Table 2009-2013 Abbott Laboratories Coronary Stent Production (10K Pieces) Price Cost Gross(USD/Piece) Production Value (10K USD) Gross Margin List 131Figure 2009-2013 Abbott Laboratories Coronary Stent Capacity Production (10K Pieces) andGrowth Rate 132Table Medtronic Company Information Table (Products Applications Manufacturing Base CapacityExpansion Market Position Contact Information Etc 13 Items) 133Figure Medtronic Medical Device Brands List 135Figure Medtronic China Coronary Stent Sales Integrity Products List 136Table 2009-2013 Medtronic Coronary Stent Production (10K Pieces) Price Cost Gross(USD/Piece) Production Value (10K USD) Gross Margin List 137Figure 2009-2013 Medtronic Coronary Stent Capacity Production (10K Pieces) and Growth Rate137Table J&J Cordis Company Information Table (Products Applications Manufacturing BaseCapacity Expansion Market Position Contact Information Etc 13 Items) 138Table 2009-2013 J&J Cordis Coronary Stent Production (10K Pieces) Price Cost Gross(USD/Piece) Production Value (10K USD) Gross Margin List 139Figure 2009-2013 J&J Cordis Coronary Stent Capacity Production (10K Pieces) and GrowthRate 139Table Biosensors International Company Information Table (Products Applications ManufacturingBase Capacity Expansion Market Position Contact Information Etc 13 Items) 140Figure Biosensors International Coronary Stent Product List 142Figure Biosensors International Coronary Stent Functions List 143
  9. 9. Table 2009-2013 Biosensors International Coronary Stent Production (10K Pieces) Price CostGross (USD/Piece) Production Value (10K USD) Gross Margin List 143Figure 2009-2013 Biosensors International Coronary Stent Capacity Production (10K Pieces) andGrowth Rate 144Table Biotronik Company Information Table (Products Applications Manufacturing Base CapacityExpansion Market Position Contact Information Etc 13 Items) 145Figure Biotronik Coronary Drug Eluting Stent System Lekton Motion 147Figure Biotronik DREAMS - Drug Eluting Absorbable Metal Scaffold 148Figure Biotronik DREAMS based on proprietary magnesium technology 149Figure Biotronik DREAMS - Key Features 149Figure Biotronik Degradation process for DREAMS 150Table 2009-2013 Biotronik Coronary Stent Production (10K Pieces) Price Cost Gross (USD/Piece)Production Value (10K USD) Gross Margin List 150Figure 2009-2013 Biotronik Coronary Stent Capacity Production (10K Pieces) and Growth Rate151Table OrbusNeich Company Information Table (Products Applications Manufacturing BaseCapacity Expansion Market Position Contact Information Etc 13 Items) 151Figure OrbusNeich Global Sales Network 154Figure OrbusNeich Coronary Stent Product List 155Figure OrbusNeich CONSTANT™ Coronary Stent 155Table OrbusNeichCONSTANT™ Coronary Stent Products Information 156Figure OrbusNeichR stent Evolution™ 2Coronary Stent 156Table 2009-2013 OrbusNeich Coronary Stent Production (10K Pieces) Price Cost Gross(USD/Piece) Production Value (10K USD) Gross Margin List 157Table 2009-2013 OrbusNeich Coronary Stent Capacity Production (10K Pieces) and GrowthRate 158Table Sorin Group Company Information Table (Products Applications Manufacturing BaseCapacity Expansion Market Position Contact Information Etc 13 Items) 158Figure Sorin Group Revenue by Regions 160Table 2009-2013 Sorin Group Coronary Stent Production (10K Pieces) Price Cost Gross(USD/Piece) Production Value (10K USD) Gross Margin List 161Figure 2009-2013 Sorin Group Coronary Stent Capacity Production (10K Pieces) and GrowthRate 161Table B.Braun Company Information Table (Products Applications Manufacturing Base CapacityExpansion Market Position Contact Information Etc 13 Items) 162Table B.Braun Coroflex Blue Coronary Stent Product Specifications List 163Table 2009-2013 B.Braun Coronary Stent Production (10K Pieces) Price Cost Gross (USD/Piece)Production Value (10K USD) Gross Margin List 164Figure 2009-2013 B.Braun Coronary Stent Capacity Production (10K Pieces) and Growth Rate165Table C. R. Bard Company Information Table (Products Applications Manufacturing BaseCapacity Expansion Market Position Contact Information Etc 13 Items) 165
  10. 10. Table 2009-2013 C. R. Bard Coronary Stent Production (10K Pieces) Price Cost Gross(USD/Piece) Production Value (10K USD) Gross Margin List 167Figure 2009-2013 C. R. Bard Coronary Stent Capacity Production (10K Pieces) and GrowthRate 168Table MicroPort Company Information Table (Products Applications Manufacturing Base CapacityExpansion Market Position Contact Information Etc 13 Items) 168Figure MicroPort Mustang Coronary Stent (BMS) 170Figure MicroPort Coronary Sirolimus-eluting Stent System Firebird 171Figure MicroPort Coronary sirolimus-eluting cobalt base alloy stent system Firebird2 173Table MicroPort Heart Firebird2 Indications List 173Table MicroPort Coronary Stent Firebird2 Diameter Length (mm) List 174Table 2009-2013 MicroPort BMS Coronary Stent Production (10K Pieces) Price Cost Gross(USD/Piece) Production Value (10K USD) Gross Margin List 174Table 2009-2013 MicroPort DES Coronary Stent Production (10K Pieces) Price Cost Gross(USD/Piece) Production Value (10K USD) Gross Margin List 174Table 2009-2013 MicroPort Coronary Stent Production (10K Pieces) Price Cost Gross(USD/Piece) Production Value (10K USD) Gross Margin List 175Figure 2009-2013 MicroPort Coronary Stent Capacity Production (10K Pieces) and Growth Rate175Table Lepu Medical Company Information Table (Products Applications Manufacturing BaseCapacity Expansion Market Position Contact Information Etc 13 Items) 176Table Lepu Medical Biguard™Rapamycin drug eluting stent systems branch System 177Figure Lepu Medical Partner ® Intravascular drug (rapamycin eluting stent system) 178Figure Lepu Medical Nano plus™Intravascular without carrier (containing rapamycin eluting stentsystem) 180Table Lepu Medical GuReater™ Cobalt base alloy of rapamycin eluting stent system 181Table 2009-2013 Lepu Medical Coronary Stent Production (10K Pieces) Price Cost Gross(USD/Piece) Production Value (10K USD) Gross Margin List 182Figure 2009-2013 Lepu Medical Coronary Stent Capacity Production (10K Pieces) and GrowthRate 182Table Jiwei Medical Systems Company Information Table (Products Applications ManufacturingBase Capacity Expansion Market Position Contact Information Etc 13 Items) 183Figure Jiwei Medical Systems EXCEL Drug Eluting Stent 185Figure Jiwei Medical Systems EXCEL) Drug Eluting Stent Product List 186Table 2009-2013 Jiwei Medical Systems Coronary Stent Production (10K Pieces) Price CostGross (USD/Piece) Production Value (10K USD) Gross Margin List 186Figure 2009-2013 Jiwei Medical Systems Coronary Stent Capacity Production (10K Pieces) andGrowth Rate 187Table Liaoning Biomedical Company Information Table (Products Applications ManufacturingBase Capacity Expansion Market Position Contact Information Etc 13 Items) 188Figure Liaoning Biomedical Drug Eluting Stent System (Dalian Genyi DES) 190Table Liaoning Biomedical Drug Eluting Stent System Product List 190
  11. 11. Table 2009-2013 Liaoning Biomedical Coronary Stent Production (10K Pieces) Price Cost Gross(USD/Piece) Production Value (10K USD) Gross Margin List 191Figure 2009-2013 Liaoning Biomedical Coronary Stent Capacity Production (10K Pieces) andGrowth Rate 191Table Vascore Company Information Table (Products Applications Manufacturing Base CapacityExpansion Market Position Contact Information Etc 13 Items) 192Figure Vascore Coronary Stent Product Picture 193Figure VascorePolymer-Free DES Product Picture 193Table 2009-2013 Vascore Coronary Stent Production (10K Pieces) Price Cost Gross (USD/Piece)Production Value (10K USD) Gross Margin List 194Figure 2009-2013 Vascore Coronary Stent Capacity Production (10K Pieces) and Growth Rate194Table Sinomed Company Information Table (Products Applications Manufacturing Base CapacityExpansion Market Position Contact Information Etc 13 Items) 195Figure Sinomed Drug Eluting StentBuMATM 196Table SinomedBuMATM Coronary Stent Product Specifications List 197Table SinomedBuMATM Coronary Stent Product List 198Table SinomedBuMATM Conveying System Table 198Table 2009-2013 Sinomed Coronary Stent Production (10K Pieces) Price Cost Gross (USD/Piece)Production Value (10K USD) Gross Margin List 198Figure 2009-2013 Sinomed Coronary Stent Capacity Production (10K Pieces) and Growth Rate199Table ESSEN Company Information Table (Products Applications Manufacturing Base CapacityExpansion Market Position Contact Information Etc 13 Items) 199Figure ESSEN Tivoli DES Coronary Stent 201Table Coronary Stent Raw Materials Sources List 206Table Coronary Stent Product Line Equipments List 207Table Coronary Heart Disease Three Type Clinical Classifications and Treatment Mode 209Table China and International Medical Device Marketing Method Comparison 216Table Power Stent DES Coronary Stent China Local Industrialization Process 230Figure New Project SWOT Analysis 230Table 2012 China Coronary Stent New Project SWOT Analysis List 233Table Coronary Stent New Project Buildings List 233Table 50K Piece/Year Coronary Stent Project Investment Return Rate and Feasibility Analysis234Contact: sales@reportsandreports.com for more information.

×